Orange Book product · Generic (ANDA)
LEVOCARNITINE
LEVOCARNITINE
At a glance
Mar 29, 2001
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 29, 2001
25 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVOCARNITINE
Strength
200MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 075881
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVOCARNITINE
- 1992CARNITORBrand (NDA)
NDA 020182 · LEADIANT BIOSCI INC
- 1988CARNITORBrand (NDA)
NDA 018948 · LEADIANT BIOSCI INC
- 1986CARNITORBrand (NDA)
NDA 019257 · LEADIANT BIOSCI INC
- 2025LEVOCARNITINEGeneric (ANDA)
ANDA 217430 · DEVA HOLDING AS
- 2022LEVOCARNITINEGeneric (ANDA)
ANDA 216384 · NOVITIUM PHARMA
- 2021LEVOCARNITINEGeneric (ANDA)
ANDA 212533 · SCIEGEN PHARMS
- 2019LEVOCARNITINEGeneric (ANDA)
ANDA 211676 · NOVITIUM PHARMA
- 2007LEVOCARNITINEGeneric (ANDA)
ANDA 077399 · HIKMA
- 2004LEVOCARNITINEGeneric (ANDA)
ANDA 076858 · RISING
- 2004LEVOCARNITINEGeneric (ANDA)
ANDA 076851 · RISING
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075861 · AM REGENT
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075567 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
